Cargando…
Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease
Dietary oversupply of triglycerides represent the hallmark of obesity and connected complications in the liver such as non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, which eventually progress to cirrhosis and hepatocellular carcinoma. Monoacylglycerol lipase is the last enzymat...
Autor principal: | Tardelli, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366061/ https://www.ncbi.nlm.nih.gov/pubmed/32742127 http://dx.doi.org/10.3748/wjg.v26.i25.3577 |
Ejemplares similares
-
Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote liver regeneration
por: Allaire, Manon, et al.
Publicado: (2023) -
Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis
por: Tardelli, Matteo, et al.
Publicado: (2019) -
Monoacylglycerol Lipase Regulates Fever Response
por: Sanchez-Alavez, Manuel, et al.
Publicado: (2015) -
Absence of Adiponutrin (PNPLA3) and Monoacylglycerol Lipase Synergistically Increases Weight Gain and Aggravates Steatohepatitis in Mice
por: Tardelli, Matteo, et al.
Publicado: (2021) -
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
por: Zanfirescu, Anca, et al.
Publicado: (2021)